Unit:
Κατεύθυνση Κλινικές Μελέτες: Σχεδιασμός και ΕκτέλεσηLibrary of the School of Health Sciences
Author:
Exarchou Angeliki
Supervisors info:
Ζαγουρή Φλώρα, Αναπληρώτρια Καθηγήτρια, Ιατρική Σχολή, ΕΚΠΑ
Τέρπος Ευάγγελος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Σταματελόπουλος Κίμων, Αναπληρωτής Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Original Title:
Η επίδραση της ανοσοθεραπείας και των στοχευμένων θεραπειών στον οικονομικό προϋπολογισμό του ΓΝΑ Αλεξάνδρα κατά τα έτη 2016-2018
Translated title:
The effection of immunosiology and targeted therapies in the financial budget of Alexandra hospital in the Year 2016-2018
Summary:
In recent years, immunotherapy has been a major weapon in the battle with cancer, changing the treatment and the course of some of its forms. The purpose of this study is to process the consumption of oncological drugs in the first trimester of 2016-2017-2018 respectively in patients on the oncology portion of the ALEXANDRA General Hospital and how they are affected by the use of immunotherapies and therapeutic methods. For this purpose, the statistics are used as they are recorded in the computerized system of the hospital's Pharmaceutical department and we analyze how much these consumes affect the Economic Budget of the Hospital, especially after the introduction of new pharmaceutical products belonging to the area of immunotherapy. We conclude that the use of these therapies leads to a sharp increase in pharmaceutical expenditure requiring a difference of € 1,159,099 from the first quarter of 2016 in the first quarter of 2018 only for ONGOLOGY THERAPIES. This fact marks a new period in the therapeutic regimens, as well as the cost of these therapies. In addition, it is clear that despite the rapid increase in pharmaceutical expenditure, drugs such as Nivolumab, Pembrolizumab, etc have the potential to prolong the expected survival of patients.
Main subject category:
Health Sciences
Keywords:
Immunosiology, Targeted Therapies, Financial Budget
